Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
US7241777B2 · kind B2 · utility
10Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2003 |
| Grant date | Jul 10, 2007 |
| Priority date | — |
| Expiry date | Jul 25, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention comprises the novel compounds of formula (I)wherein r, t, Y1, Y2, R1, R2, R3, R5, R6and R7 have defined meanings, having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.